The future of childhood immunizations: examining the European experience

Insights

Pediatric combination vaccines simplify immunization schedules, offering protection against multiple diseases. Their successful use in Europe suggests they will be readily accepted and widely adopted in the United States.

Area of Science:

  • Pediatric infectious disease prevention
  • Vaccinology
  • Public health policy

Background:

  • Pediatric combination vaccines protecting against multiple diseases are emerging in the US.
  • These vaccines have a proven track record of extensive use in Europe and globally.

Purpose of the Study:

  • To evaluate the European experience with pediatric combination vaccines.
  • To predict the acceptance and utilization of these vaccines in the United States.

Main Methods:

  • Review of European clinical practice and vaccine acceptance data.
  • Comparative analysis of immunization schedules in Europe and the US.

Main Results:

  • Combination vaccines have been well-received and widely adopted in Europe.
  • These vaccines simplify pediatric immunization, reducing the number of injections per visit.
  • German infants receive a maximum of 2 injections per visit with hexavalent vaccines, unlike up to 5 in the US.

Conclusions:

  • Combination vaccines offer an efficient method for simplifying pediatric immunization schedules.
  • The proven benefits and acceptance in Europe indicate a positive reception for new combination vaccines in the US.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.